Compare Icl Group Ltd (ICL) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Icl Group Ltd vs UnitedHealth Group Inc — how do they compare? Icl Group Ltd trades at $5.33 (market cap $6.76B), while UnitedHealth Group Inc trades at $431.99 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 58.6× Icl Group Ltd's market cap, and Icl Group Ltd pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| ICL | UNH | |
|---|---|---|
Market Cap | $6.76B | $396.27B |
Sector | Basic Materials | Health |
52-Week High | $7.03 | $436.35 |
52-Week Low | $4.80 | $237.77 |
Enterprise Value | $9.33B | $442.96B |
Dividend Yield | 3.63% | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICL trades at $5.25, up 3.96% today, with neutral technical signals and mixed earnings history. The company maintains stable cash flow and recently completed an $800 million senior notes offering. Valuation metrics show a P/E of 24.05 and P/S of 0.88, while profitability margins remain modest. All four covering analysts rate the stock as Hold.
Outlook is cautious due to flat analyst sentiment and declining profit margins, though operational cash flow supports dividend payments. Key risks include raw material costs and foreign exchange volatility. The stock offers income via dividends but lacks near-term growth catalysts.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
